Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00681161 · ClinicalTrials.gov registry record · NA
Autonomic Function in Obstructive Sleep Apnea
A NA study, sponsored by Vanderbilt University.
- Completed
- Registry status
- NA
- Development phase
- 70
- Enrollment target
NCT00681161: Completed NA study, sponsored by Vanderbilt University.
NCT00681161 is a NA study that has completed, run by Vanderbilt University. The registered enrollment target is 70 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00681161, a NA study, has completed, sponsored by Vanderbilt University.
- COMPLETED
- Registry status
- NA
- Development phase
- 70 participants
- Enrollment target
Study Summary
The purpose of this study is to determine if obstructive sleep apnea (OSA) causes autonomic dysfunction independent of its effects on hyperglycemia.
Interventions
- OTHER continuous positive airway pressure (CPAP)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2006-03 |
| Est. Completion | 2012-12 |
| Phase | NA |
What the finished NCT00681161 record still lists
NCT00681161 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 70 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (95% lower).
The record links to 0 conditions, and to 1 intervention - of which continuous positive airway pressure (CPAP) is the first listed.
NCT00681161 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00681161 about?
NCT00681161 is a clinical study titled "Autonomic Function in Obstructive Sleep Apnea". The purpose of this study is to determine if obstructive sleep apnea (OSA) causes autonomic dysfunction independent of its effects on hyperglycemia.
What is the current status of trial NCT00681161?
This trial is currently completed. It is a NA study. The enrollment target is 70 participants. The study started on 2006-03. Estimated completion is 2012-12.
What interventions are being tested in trial NCT00681161?
The interventions under investigation include: continuous positive airway pressure (CPAP) (OTHER).
Who is sponsoring clinical trial NCT00681161?
This trial is sponsored by Vanderbilt University, which has 430 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00681161's enrollment target sits among peer trials
70 1103rd of 2000 higher than 868 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00969111 · 70 participants · NA
Postoperative or Salvage Radiotherapy (RT) for Node Negative Prostate Cancer Following Radical Prostatectomy
- NCT01712620 · 70 participants · Phase 2
Spironolactone for Pulmonary Arterial Hypertension
- NCT02143830 · 70 participants · Phase 2
HSCT for Patients With Fanconi Anemia Using Risk-Adjusted Chemotherapy
- NCT02601339 · 70 participants
NIRS Monitoring in Premature Infants
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia